Baillie Gifford & Co. trimmed its holdings in Credicorp Ltd. (NYSE:BAP – Free Report) by 3.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 1,622,326 shares of the bank’s stock after selling 51,935 shares during the quarter. Baillie Gifford & Co.’s holdings in Credicorp were worth $297,405,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in Credicorp by 782.7% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,326,947 shares of the bank’s stock worth $240,138,000 after purchasing an additional 1,176,612 shares in the last quarter. Public Employees Retirement System of Ohio bought a new position in Credicorp in the third quarter worth approximately $42,794,000. FMR LLC grew its stake in Credicorp by 6.1% in the third quarter. FMR LLC now owns 3,446,621 shares of the bank’s stock worth $623,735,000 after purchasing an additional 199,137 shares in the last quarter. Carrhae Capital LLP bought a new position in Credicorp in the third quarter worth approximately $27,974,000. Finally, TT International Asset Management LTD bought a new position in Credicorp in the third quarter worth approximately $25,081,000. 89.81% of the stock is currently owned by hedge funds and other institutional investors.
Credicorp Stock Up 1.1 %
Shares of NYSE BAP opened at $185.81 on Monday. The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 0.66. The stock has a market capitalization of $14.78 billion, a PE ratio of 10.66, a price-to-earnings-growth ratio of 0.51 and a beta of 1.12. The stock’s fifty day simple moving average is $184.88 and its two-hundred day simple moving average is $181.78. Credicorp Ltd. has a 12-month low of $153.27 and a 12-month high of $200.00.
Analysts Set New Price Targets
BAP has been the topic of several research analyst reports. JPMorgan Chase & Co. increased their price objective on Credicorp from $200.00 to $219.00 and gave the stock an “overweight” rating in a research note on Tuesday, November 12th. Bank of America cut Credicorp from a “buy” rating to a “neutral” rating and dropped their price objective for the stock from $209.00 to $208.00 in a research note on Monday, December 16th.
Read Our Latest Research Report on Credicorp
Credicorp Company Profile
Credicorp Ltd. provides various financial, insurance, and health services and products primarily in Peru and internationally. It operates through Universal Banking, Insurance and Pensions, Microfinance, and Investment Banking and Equity Management segments. The Universal Banking segment grants various credits and financial instruments to individuals and legal entities; and various deposits and current accounts.
Further Reading
- Five stocks we like better than Credicorp
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Symbotic Shares Down 37%—Is It Time for Bravery or Caution?
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- High-Yield Healthcare: 3 Stocks With Strong Dividends
- What Are Trending Stocks? Trending Stocks Explained
- Beyond the Bargain Bin: 3 Stocks Leading Discount Retail
Want to see what other hedge funds are holding BAP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Credicorp Ltd. (NYSE:BAP – Free Report).
Receive News & Ratings for Credicorp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Credicorp and related companies with MarketBeat.com's FREE daily email newsletter.